Successful treatment with rituximab of pure red cell aplasia in allogeneic bone marrow transplant with major ABO mismatch

被引：0
|
作者：
Bazarbachi, A [1 ]
El Sayyad, M [1 ]
Baz, EMK [1 ]
机构：
[1] Amer Univ Beirut, Beirut, Lebanon
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [21] Pure red cell aplasia following allogeneic bone marrow transplantation.
    Barta, A
    Batai, A
    Torbagyi, E
    Gopcsa, L
    Petranyi, GG
    Kelemen, E
    Paloczi, K
    BONE MARROW TRANSPLANTATION, 1998, 21 : S52 - S52
  • [22] Allogeneic bone marrow transplantation (BMT) for pure red cell aplasia.
    Massumoto, C
    Graziani, S
    Rosa, MF
    Migliorati, C
    Fujimura, A
    Granja, I
    BLOOD, 1999, 94 (10) : 323B - 323B
  • [23] Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib
    L-M Poon
    L P Koh
    Bone Marrow Transplantation, 2012, 47 : 870 - 871
  • [24] Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib
    Poon, L-M
    Koh, L. P.
    BONE MARROW TRANSPLANTATION, 2012, 47 (06) : 870 - 871
  • [25] TREATMENT OF PURE RED-CELL APLASIA AFTER MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION RESISTANT TO ERYTHROPOIETIN
    OHASHI, K
    AKIYAMA, H
    TAKAMOTO, S
    TANIKAWA, S
    SAKAMAKI, H
    ONOZAWA, Y
    BONE MARROW TRANSPLANTATION, 1994, 13 (03) : 335 - 336
  • [26] TREATMENT OF PURE RED-CELL APLASIA AFTER MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION WITH RECOMBINANT ERYTHROPOIETIN
    HEYLL, A
    AUL, C
    RUNDE, V
    ARNING, M
    SCHNEIDER, W
    WERNET, P
    BLOOD, 1991, 77 (04) : 906 - 906
  • [27] Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
    J-H Lee
    K-H Lee
    S Kim
    J-S Lee
    S-H Kim
    S-W Kwon
    W-K Kim
    Bone Marrow Transplantation, 2000, 25 : 179 - 184
  • [28] Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
    Lee, JH
    Lee, KH
    Kim, S
    Lee, JS
    Kim, SH
    Kwon, SW
    Kim, WK
    BONE MARROW TRANSPLANTATION, 2000, 25 (02) : 179 - 184
  • [29] PURE RED CELL APLASIA IN MAJOR ABO INCOMPATIBLE ALLOGENEIC STEM CELL TRANSPLANT: RETOSPECTIVE ANALYSIS FROM A SINGLE CENTER EXPERIENCE
    Alonso Castronuno, David
    Cabrero, Monica
    Fonseca, Marta
    Alejo, Elena
    Maria Navarro, Jose
    Hernandez, Alberto
    Puertas, Borja
    Patricia Gomez, Sandra
    Puerta, Carlos
    Zapata, Evelyn
    Garcia, Pablo
    Africa Martin, Ana
    Lopez-Parra, Miriam
    Luisa Martin-Mateos, Maria
    Perez-Lopez, Estefania
    Baile, Monica
    Cabero, Almudena
    Avendano, Alejandro
    De Ramon, Cristina
    Garcia-Bacelar, Ana
    Vazquez, Lourdes
    Sanchez-Guijo, Fermin
    Lopez-Villar, Olga
    Lopez-Corral, Lucia
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 520 - 521
  • [30] Erythropoietic Stimulating Agents for Pure Red Cell Aplasia Following Major ABO Mismatch T-deplete Allogeneic Stem Cell Transplants
    Mehra, V.
    Pearse, O.
    Walker, R.
    de Lavallade, H.
    McIornan, D.
    Pagliuca, T.
    Mufti, G.
    Raj, K.
    Potter, V.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 153 - 153
12345